Blood test study to track markers in diabetes
Part of Hormones & metabolism clinical trials.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can (or your guardian can) sign informed consent/assent to join
- You’re in one of these groups: type 1 diabetes, adult type 2 diabetes, antibody-positive people without diabetes (certain A1c range), or adults with prediabetes or low A1c as a control
- Your weight is at least 30 kg
- You’re willing to provide blood samples (up to about 100 mL if applicable) and allow review of medical records or lab results
- You do not have key exclusions like active infection or currently treated cancer
- You haven’t had certain immune-modifying treatments in the last year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a wearable sensor (like a smartwatch) to track your body's signals when blood sugar drops low. The goal is to understand low blood sugar patterns better, which may help improve prevention and treatment.
This study measures how “blood fats” move in the body after fasting and controlled eating, comparing people with type 1 diabetes to those without diabetes. It may help researchers understand diabetes-related differences in lipid (fat) handling and improve future treatments.
This study looks at how your immune system changes over time and how that relates to developing type 1 diabetes. You may be able to join if you can have blood drawn, since the study focuses on blood samples.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
This study checks if people with diabetes can safely collect their own blood samples at home for routine check-ups. It aims to make monitoring more convenient.
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.